BioSpace News Archive

Biotech Beach

Dovetail Genomics Introduces its First Commercial Service for Analysis of Human Genomes

Applications of the technique range from oncology and undiagnosed disease research, to retrospective analysis of clinical trials.

February 12, 2018

·

3 min read

Genetown

PAREXEL Introduces Biological Sample Lifecycle Management Service to Address Growing Demand Across Drug Development

PAREXEL today launched its Biological Sample Lifecycle Management service, enabling optimal use of human biological samples.

February 12, 2018

·

3 min read

Biotech Beach

Endonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical Device

Animals treated three times per day with the Company’s Pulsed Electromagnetic Fields device had significantly higher blood flow at day 7 and 14.

February 12, 2018

·

4 min read

Congenica and SFI Research Centre FutureNeuro Unite to Deliver More Accurate Diagnoses for Genetic Epilepsy

The alliance between Congenica and FutureNeuro, will further help the evolving understanding of the causes of many types of epilepsy and will also help to progress the exciting clinical alliance between genomics and electronic health records.

February 12, 2018

·

3 min read

Drug Development

Cincinnati Children’s Hospital Medical Center Release: Study Suggests Way to Attack Deadly, Untreatable Nerve Tumors

Genomic profiling of mostly untreatable and deadly nerve sheath tumors led scientists to test a possible therapeutic strategy that inhibited tumor growth in lab tests on human tumor cells and mouse models, according to research in the journal Cancer Cell.

February 12, 2018

·

3 min read

Drug Development

Rexahn Reports Data From the Ongoing Phase IIa Clinical Trial of RX-3117 in Advanced Bladder Cancer at the American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) 2018 Annual Meeting

The poster presentation reported interim data on the Phase 2a clinical trial of RX-3117 monotherapy for the treatment of advanced bladder cancer.

February 12, 2018

·

6 min read

Business

Horizon Discovery Enters into License Agreement With U.S. Immuno-Oncology Company

Horizon has licensed to the Partner a novel cell line engineering technology as well as non-exclusive rights to Horizon’s proprietary Helitron transposon gene editing technology for an undisclosed financial consideration.

February 12, 2018

·

6 min read

Business

Oncoceutics Announces Appointment of Dr. Minesh Mehta to the Board of Directors

Oncoceutics announced the appointment of Minesh Mehta, MD, FASTRO, to the company’s Board of Directors.

February 12, 2018

·

2 min read

Business

Luminex Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results

Fourth quarter and full-year 2017 consolidated revenue was $78.2 million and $306.6 million, an increase of 8% and 13%, respectively, compared to the fourth quarter and full-year 2016.

February 12, 2018

·

25 min read

Business

Lantheus Holdings to Host Fourth Quarter and Full Year 2017 Earnings Conference Call and Provide 2018 Guidance on February 26, 2018 at 4:30 p.m. Eastern Time

The Company will also provide guidance for 2018.

February 12, 2018

·

1 min read